IDDF2022-ABS-0196 The role of circulating tumor cells in peripheral blood as an adjunctive non-invasive diagnostic methods for colorectal cancer

Saskia aziza Nursyirwan; Dimas ramadhian Noor; Murdani Abdullah; Wifanto saditya Jeo; Nur Rahadiani; Diah rini Handjari; Achmad Fauzi; Kaka Renaldi; Hasan Maulahela; Amanda pitarini Utari; Rabbinu rangga Pribadi; Virly nanda Muzellina; Muhammad firhat Idrus

doi:10.1136/gutjnl-2022-IDDF.220

IDDF2022-ABS-0196 The role of circulating tumor cells in peripheral blood as an adjunctive non-invasive diagnostic methods for colorectal cancer

Saskia aziza Nursyirwan, Dimas ramadhian Noor, Murdani Abdullah, Wifanto saditya Jeo, Nur Rahadiani, Diah rini Handjari, Achmad Fauzi, Kaka Renaldi, Hasan Maulahela, Amanda pitarini Utari, Rabbinu rangga Pribadi, Virly nanda Muzellina, Muhammad firhat Idrus

Research output: Contribution to conference › Paper › peer-review

Abstract

Colorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality. The gold standard for diagnosing colorectal cancer is histopathology, which is obtained from a biopsy during colonoscopy. Since not all patients are willing to undergo invasive testing at the outset of the first diagnostic plan, new non-invasive approaches that can complement and enhance strategies for non-invasive diagnosis and management of colorectal cancer are urgently needed. Circulating tumor cells (CTC) in the blood are expected to be used as a non-invasive diagnostic marker in patients with CRC. This research is a diagnostic test of CTC on CRC using the isolation and analysis of the negative selection immunomagnetic method with Easysep™ and CD44 cancer mesenchymal marker.

Original language	English
Pages	A157.1-A157
DOIs	https://doi.org/10.1136/gutjnl-2022-IDDF.220
Publication status	Published - 2 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/gutjnl-2022-IDDF.220

https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2022-IDDF.220

Cite this

Nursyirwan, S. A., Noor, D. R., Abdullah, M., Jeo, W. S., Rahadiani, N., Handjari, D. R., Fauzi, A., Renaldi, K., Maulahela, H., Utari, A. P., Pribadi, R. R., Muzellina, V. N., & Idrus, M. F. (2022). IDDF2022-ABS-0196 The role of circulating tumor cells in peripheral blood as an adjunctive non-invasive diagnostic methods for colorectal cancer. A157.1-A157. https://doi.org/10.1136/gutjnl-2022-IDDF.220

@conference{dcacff283b664985927713001a4ab269,

title = "IDDF2022-ABS-0196 The role of circulating tumor cells in peripheral blood as an adjunctive non-invasive diagnostic methods for colorectal cancer",

abstract = "Colorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality. The gold standard for diagnosing colorectal cancer is histopathology, which is obtained from a biopsy during colonoscopy. Since not all patients are willing to undergo invasive testing at the outset of the first diagnostic plan, new non-invasive approaches that can complement and enhance strategies for non-invasive diagnosis and management of colorectal cancer are urgently needed. Circulating tumor cells (CTC) in the blood are expected to be used as a non-invasive diagnostic marker in patients with CRC. This research is a diagnostic test of CTC on CRC using the isolation and analysis of the negative selection immunomagnetic method with Easysep{\texttrademark} and CD44 cancer mesenchymal marker.",

author = "Nursyirwan, {Saskia aziza} and Noor, {Dimas ramadhian} and Murdani Abdullah and Jeo, {Wifanto saditya} and Nur Rahadiani and Handjari, {Diah rini} and Achmad Fauzi and Kaka Renaldi and Hasan Maulahela and Utari, {Amanda pitarini} and Pribadi, {Rabbinu rangga} and Muzellina, {Virly nanda} and Idrus, {Muhammad firhat}",

year = "2022",

month = sep,

day = "2",

doi = "10.1136/gutjnl-2022-IDDF.220",

language = "English",

pages = "A157.1--A157",

}

Nursyirwan, SA, Noor, DR, Abdullah, M , Jeo, WS , Rahadiani, N, Handjari, DR, Fauzi, A , Renaldi, K, Maulahela, H, Utari, AP, Pribadi, RR, Muzellina, VN & Idrus, MF 2022, 'IDDF2022-ABS-0196 The role of circulating tumor cells in peripheral blood as an adjunctive non-invasive diagnostic methods for colorectal cancer', pp. A157.1-A157. https://doi.org/10.1136/gutjnl-2022-IDDF.220

TY - CONF

T1 - IDDF2022-ABS-0196 The role of circulating tumor cells in peripheral blood as an adjunctive non-invasive diagnostic methods for colorectal cancer

AU - Nursyirwan, Saskia aziza

AU - Noor, Dimas ramadhian

AU - Abdullah, Murdani

AU - Jeo, Wifanto saditya

AU - Rahadiani, Nur

AU - Handjari, Diah rini

AU - Fauzi, Achmad

AU - Renaldi, Kaka

AU - Maulahela, Hasan

AU - Utari, Amanda pitarini

AU - Pribadi, Rabbinu rangga

AU - Muzellina, Virly nanda

AU - Idrus, Muhammad firhat

PY - 2022/9/2

Y1 - 2022/9/2

N2 - Colorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality. The gold standard for diagnosing colorectal cancer is histopathology, which is obtained from a biopsy during colonoscopy. Since not all patients are willing to undergo invasive testing at the outset of the first diagnostic plan, new non-invasive approaches that can complement and enhance strategies for non-invasive diagnosis and management of colorectal cancer are urgently needed. Circulating tumor cells (CTC) in the blood are expected to be used as a non-invasive diagnostic marker in patients with CRC. This research is a diagnostic test of CTC on CRC using the isolation and analysis of the negative selection immunomagnetic method with Easysep™ and CD44 cancer mesenchymal marker.

AB - Colorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality. The gold standard for diagnosing colorectal cancer is histopathology, which is obtained from a biopsy during colonoscopy. Since not all patients are willing to undergo invasive testing at the outset of the first diagnostic plan, new non-invasive approaches that can complement and enhance strategies for non-invasive diagnosis and management of colorectal cancer are urgently needed. Circulating tumor cells (CTC) in the blood are expected to be used as a non-invasive diagnostic marker in patients with CRC. This research is a diagnostic test of CTC on CRC using the isolation and analysis of the negative selection immunomagnetic method with Easysep™ and CD44 cancer mesenchymal marker.

U2 - 10.1136/gutjnl-2022-IDDF.220

DO - 10.1136/gutjnl-2022-IDDF.220

M3 - Paper

SP - A157.1-A157

ER -

IDDF2022-ABS-0196 The role of circulating tumor cells in peripheral blood as an adjunctive non-invasive diagnostic methods for colorectal cancer

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this